Efficacy of Intranasal Administration of the Recombinant Endolysin SAL200 in a Lethal Murine Staphylococcus aureus Pneumonia Model. [electronic resource]
- Antimicrobial agents and chemotherapy 04 2019
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1098-6596
10.1128/AAC.02009-18 doi
Administration, Intranasal Animals Anti-Bacterial Agents--therapeutic use Bacterial Load--drug effects Cytokines--blood Disease Models, Animal Endopeptidases--therapeutic use Female Mice Mice, Inbred BALB C Pneumonia, Staphylococcal--drug therapy Staphylococcus aureus--drug effects